Frontlight ResearchEarly access
Huntington's disease trials in Canada
5 of 7 trials · From ClinicalTrials.gov, checked 15 November 2026. Ask the study team whether a trial fits you.
- Phase 2/3Taking peopleStudy to Evaluate the Pharmacodynamics, Safety and Efficacy of SKY-0515 in Participants With Huntington's Disease
- Where
- Toronto
- Age
- 25 years and over
- People
- 400 worldwide
- Run by
- Skyhawk Therapeutics, Inc.
See details and how to joinNCT07378644 · EU 2025-522263-14-00 - Phase 3Not yet taking people in CanadaPridopidine Phase 3 Study in Huntington's Disease
- Where
- Calgary, Edmonton, Montreal, Toronto, Vancouver
- Age
- 23 years to 65 years
- People
- 400 worldwide
- Run by
- Prilenia
See details and how to joinNCT07609108 · EU 2026-526093-16-00 - Phase 1Taking peopleA Study to Evaluate ALN-HTT02 in Adult Patients With Huntington's Disease
- Where
- Edmonton, Montreal, Ottawa, Vancouver
- Age
- 25 years to 70 years
- People
- 66 worldwide
- Run by
- Alnylam Pharmaceuticals
See details and how to joinNCT06585449 - Phase 3Taking peopleA Study to Investigate the Efficacy, Safety and Tolerability of Votoplam in Participants With Huntington's Disease
- Where
- Montreal, North York
- Age
- 21 years to 70 years
- People
- 770 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT07326709 · EU 2025-522227-99-00 - Phase 3Enrolling by invitationLong-term Study to Evaluate Safety and Tolerability of Valbenazine in Participants With Chorea Associated With Huntington Disease in Canada
- Where
- Ottawa, Toronto, Vancouver
- Age
- 18 years and over
- People
- 7
- Run by
- Neurocrine Biosciences
See details and how to joinNCT06312189